Citeline's AI-powered Trialtrove+, Sitetrove+ and Investigator SmartSelect support feasibility benchmarking before protocol finalization.
Sponsors struggle to benchmark feasibility, find suitable sites and predict recruitment before the protocol is final. Citeline's tools draw on more than 60,000 trusted global inputs. The page documents capabilities, not quantified outcomes.
Citeline is a pharma intelligence provider whose Trialtrove, Sitetrove and SmartSolutions are used for trial benchmarking, protocol design and site selection
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Citeline on its own site — read the original case study on citeline.com ↗
Note: Use-case overview with no customer results.
Related use cases
- 01A mid-size biopharma used Trialtrove+ and Sitetrove+ to benchmark and select sites with confidence.
- 02A global pharma used Citeline's AI SmartSolutions for protocol design and investigator selection in a breast cancer trial.
- 03How Bioventus evolved their commercial strategy with real world data and intelligence
- 04Clarivate and CLEO diagnostics are making early detection of ovarian cancer a reality
- 05Making informed investment decisions (Attracting breakthrough innovations from academic research) - SPRIND case study
- 06Gedeon Richter — Case study | Clarivate Regulatory Intelligence Tracking Application